BioCentury
ARTICLE | Clinical News

THN102: Phase Ib started

November 9, 2015 8:00 AM UTC

Theranexus began a double-blind, placebo-controlled, French Phase Ib trial to evaluate 3 doses of THN102 in sleep-deprived volunteers. ...